Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
The Intergroup | INTG | Jan 28, 2025 | 13.65 | +15.09 |
The J.M Smucker Company | SJM | Jan 28, 2025 | 105.33 | -1.83 |
The Joint | JYNT | Jan 28, 2025 | 11.29 | +1.44 |
The Marygold Companies | MGLD | Jan 28, 2025 | 1.04 | -5.45 |
The ODP | ODP | Jan 28, 2025 | 23.56 | -0.46 |
The OLB Group | OLB | Jan 28, 2025 | 1.38 | +5.77 |
The Oncology Institute | TOI | Jan 28, 2025 | 0.79 | +0.87 |
The ONE Group Hospitality | STKS | Jan 28, 2025 | 3.72 | -3.38 |
The Pennant Group | PNTG | Jan 28, 2025 | 26.68 | -2.24 |
The Real Brokerage | REAX | Jan 28, 2025 | 4.99 | +3.96 |
The Real Estate Select Sector SPDR Fund | XLRE | Jan 28, 2025 | 41.45 | -1.22 |
The RealReal | REAL | Jan 28, 2025 | 9.53 | +3.14 |
The RMR Group A | RMR | Jan 28, 2025 | 18.33 | -3.98 |
The Shyft Group | SHYF | Jan 28, 2025 | 12.02 | -1.80 |
The Trade Desk A | TTD | Jan 28, 2025 | 120.56 | +1.23 |
The9 ADR | NCTY | Jan 28, 2025 | 15.47 | +4.53 |
TherapeuticsMD | TXMD | Jan 28, 2025 | 1.09 | -6.03 |
Theratechnologies | THTX | Jan 28, 2025 | 1.64 | +0.61 |
Theravance Biopharma | TBPH | Jan 28, 2025 | 9.83 | +1.65 |
Theriva Biologics | TOVX | Jan 28, 2025 | 1.29 | -3.73 |
Thermo Fisher Scientific | TMO | Jan 28, 2025 | 584.29 | +0.11 |
Thermon Group | THR | Jan 28, 2025 | 28.04 | -3.24 |
Third Coast Bancshares | TCBX | Jan 28, 2025 | 37.05 | +0.62 |
Third Harmonic | THRD | Jan 28, 2025 | 5.29 | -0.66 |
Thomson Reuters | TRI | Jan 28, 2025 | 166.20 | +0.97 |
Thor Industries | THO | Jan 28, 2025 | 101.52 | -2.47 |
Thornburg Income Builder Opportunities Fund | TBLD | Jan 28, 2025 | 16.90 | +0.12 |
ThredUp A | TDUP | Jan 28, 2025 | 2.15 | +2.38 |
Thryv | THRY | Jan 28, 2025 | 17.12 | +0.35 |
Thumzup Media | TZUP | Jan 28, 2025 | 3.55 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.